WILMINGTON, Mass. (AP) _ Charles River Laboratories International Inc. (CRL) on Wednesday reported fourth-quarter net income of $59.7 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Wilmington, Massachusetts-based company said it had profit of $1.21. Earnings, adjusted for one-time gains and costs, were $1.49 per share.
The results exceeded Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $1.39 per share.
The medical research equipment and services provider posted revenue of $601.5 million in the period, also topping Street forecasts. Eight analysts surveyed by Zacks expected $590.1 million.
For the year, the company reported profit of $226.4 million, or $4.62 per share. Revenue was reported as $2.27 billion.
Charles River expects full-year earnings in the range of $6.25 to $6.40 per share.
Charles River shares have risen 14 percent since the beginning of the year. The stock has increased 27 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRL at https://www.zacks.com/ap/CRL